Literature DB >> 29997922

Risk factors for mortality in ICU patients with Acinetobacter baumannii ventilator-associated pneumonia: impact of bacterial cytotoxicity.

Mohan Ju1, Dongni Hou1, Shu Chen2, Ying Wang1, Xinjun Tang1, Jie Liu1, Cuicui Chen1, Yuanlin Song1, Huayin Li1.   

Abstract

BACKGROUND: Acinetobacter baumannii (A. baumannii) ventilator-associated pneumonia (VAP) in intensive care unit (ICU) is associated with high morbidity and mortality in patients with critical illness. However, the literatures that focused on the short-term prognosis and the risk factors for mortality are limited. The aim of this study was to evaluate the risk factors for mortality in ICU patients with A. baumannii VAP.
METHODS: A retrospective cohort study was conducted in the medical/surgical ICU at Zhongshan Hospital in Shanghai, China. Adult patients meeting the criteria of A. baumannii VAP from January 2012 to October 2015 were enrolled. Apart from collecting clinical and microbiologic data, we performed biofilm-formation and cytotoxicity testing using A. baumannii strains which are isolated from patients. Multivariate logistic regression analysis was used to determine the independent risk factors for 30-day mortality in ICU.
RESULTS: Seventy-eight patients were included in this study. The 30-day mortality rate in ICU for the patients was 37.2%. Multivariate analysis revealed that short-term mortality was significantly associated with prior surgery [OR, 0.277; 95% confidence interval (CI), 0.089-0.866; P=0.027], higher APACHEII score (OR, 1.140; 95% CI, 1.007-1.291; P=0.038) and an increased bacterial cytotoxicity (OR, 1.029 ; 95% CI, 1.001-1.058; P=0.047).
CONCLUSIONS: The main finding of our study was that increased bacterial cytotoxicity might be a risk factor for short-term mortality in ICU patients with A. baumannii VAP.

Entities:  

Keywords:  Acinetobacter baumannii (A. baumannii); cytotoxicity; intensive care unit; prognosis; ventilator-associated pneumonia (VAP)

Year:  2018        PMID: 29997922      PMCID: PMC6006127          DOI: 10.21037/jtd.2018.04.86

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  35 in total

1.  European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing.

Authors:  G Kahlmeter; D F J Brown; F W Goldstein; A P MacGowan; J W Mouton; I Odenholt; A Rodloff; C-J Soussy; M Steinbakk; F Soriano; O Stetsiouk
Journal:  Clin Microbiol Infect       Date:  2006-06       Impact factor: 8.067

2.  Multidrug Resistance Acinetobacter Bacteremia Secondary to Ventilator-Associated Pneumonia: Risk Factors and Outcome.

Authors:  Evgeni Brotfain; Abraham Borer; Leonid Koyfman; Lisa Saidel-Odes; Amit Frenkel; Shaun E Gruenbaum; Vsevolod Rosenzweig; Alexander Zlotnik; Moti Klein
Journal:  J Intensive Care Med       Date:  2016-02-21       Impact factor: 3.510

3.  Acinetobacter baumannii and A. pittii clinical isolates lack adherence and cytotoxicity to lung epithelial cells in vitro.

Authors:  María Lázaro-Díez; Teresa Navascués-Lejarza; Sara Remuzgo-Martínez; Jesús Navas; José Manuel Icardo; Felix Acosta; Luis Martínez-Martínez; José Ramos-Vivas
Journal:  Microbes Infect       Date:  2016-05-24       Impact factor: 2.700

4.  Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection.

Authors:  Yi-Tzu Lee; Shu-Chen Kuo; Su-Pen Yang; Yi-Tsung Lin; Fan-Chen Tseng; Te-Li Chen; Chang-Phone Fung
Journal:  Clin Infect Dis       Date:  2012-04-11       Impact factor: 9.079

5.  Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam.

Authors:  Ronen Zalts; Ami Neuberger; Khetam Hussein; Ayelet Raz-Pasteur; Yuval Geffen; Tanya Mashiach; Renato Finkelstein
Journal:  Am J Ther       Date:  2016 Jan-Feb       Impact factor: 2.688

6.  Incidence and outcomes of ventilator-associated tracheobronchitis and pneumonia.

Authors:  Donald E Craven; Yuxiu Lei; Robin Ruthazer; Akmal Sarwar; Jana Hudcova
Journal:  Am J Med       Date:  2013-04-02       Impact factor: 4.965

7.  Acinetobacter is the most common pathogen associated with late-onset and recurrent ventilator-associated pneumonia in an adult intensive care unit in Saudi Arabia.

Authors:  Aiman El-Saed; Hanan H Balkhy; Hasan M Al-Dorzi; Raymond Khan; Asgar H Rishu; Yaseen M Arabi
Journal:  Int J Infect Dis       Date:  2013-03-19       Impact factor: 3.623

8.  MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline).

Authors:  Martin G Lamarche; Eric Déziel
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

9.  Evaluation of semi-quantitative scoring of Gram staining or semi-quantitative culture for the diagnosis of ventilator-associated pneumonia: a retrospective comparison with quantitative culture.

Authors:  Soshi Hashimoto; Nobuaki Shime
Journal:  J Intensive Care       Date:  2013-10-23

10.  Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia.

Authors:  Juthamas Inchai; Chaicharn Pothirat; Chaiwat Bumroongkit; Atikun Limsukon; Weerayut Khositsakulchai; Chalerm Liwsrisakun
Journal:  J Intensive Care       Date:  2015-03-02
View more
  3 in total

1.  Different clinical characteristics and impact of carbapenem-resistance on outcomes between Acinetobacter baumannii and Pseudomonas aeruginosa bacteraemia: a prospective observational study.

Authors:  Chan Mi Lee; Young-Jun Kim; Kyung-Hwa Park; Kyoung-Ho Song; Sook-In Jung; Seong Eun Kim; Wan Beom Park; Pyoeng Gyun Choe; Eu Suk Kim; Chung-Jong Kim; Hee Jung Choi; Shinwon Lee; Sun Hee Lee; Younghee Jung; Ji Hwan Bang; Shinhye Cheon; Yee Gyung Kwak; Yu Min Kang; Hong Bin Kim
Journal:  Sci Rep       Date:  2022-05-20       Impact factor: 4.996

2.  Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome.

Authors:  Bukhari Elham; Alotaibi Fawzia
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927

3.  Risk Factors for Mortality Due to Ventilator-Associated Pneumonia in a Chinese Hospital: A Retrospective Study.

Authors:  Ding-Yun Feng; Yu-Qi Zhou; Mi Zhou; Xiao-Ling Zou; Yan-Hong Wang; Tian-Tuo Zhang
Journal:  Med Sci Monit       Date:  2019-10-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.